Literature DB >> 10952580

Accumulation of norfloxacin by Bacteroides fragilis.

V Ricci1, L J Piddock.   

Abstract

The accumulation of norfloxacin by Bacteroides fragilis NCTC 9343 was determined by the modified fluorescence method. The time required to achieve a steady-state concentration (SSC) after allowing B. fragilis to accumulate norfloxacin in an aerobic or an anaerobic environment was approximately 2 min; the SSC achieved in air was 90.28 +/- 9.32 ng of norfloxacin/mg (dry weight) of cells, and that achieved anaerobically was 98.45 +/- 3.7 ng of norfloxacin/mg (dry weight) of cells. Initial rates of accumulation were determined with a range of external concentrations, as up to 8 microg/ml the concentration of norfloxacin accumulated increased proportionally to the external concentration, 12.13 ng/mg (dry weight) of cells per microg of exogenous norfloxacin per ml. At concentrations above 10 microg/ml no increase in the rate of norfloxacin accumulation was observed. From the kinetic data, a Lineweaver-Burk plot calculated a K(m) of 5.03 microg/ml and a V(max) of 25.1 ng of norfloxacin/s. With an increase in temperature of between 0 and 30 degrees C, the concentration of norfloxacin accumulated also increased proportionally at 4.722 ng of norfloxacin/mg (dry weight) of cells/ degrees C. At low concentrations of glucose (<0.2%; 11 mM), the concentration of norfloxacin accumulated was decreased. With the addition of 100 microM carbonyl cyanide m-chlorophenylhydrazone (CCCP) the mean SSC of norfloxacin was increased to 116 +/- 7.01 ng of norfloxacin/mg (dry weight) of cells; glucose had no significant effect in the presence of CCCP. Magnesium chloride (20 mM) decreased the SSC of norfloxacin to 40.5 +/- 3.76 ng of norfloxacin per mg (dry weight) of cells. These data suggest that the mechanism of accumulation of norfloxacin by B. fragilis is similar to that of aerobic bacteria and that the fluoresence procedure is suitable for use with an anaerobic bacterium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952580      PMCID: PMC90070          DOI: 10.1128/AAC.44.9.2361-2366.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.

Authors:  M A Cooper; J M Andrews; R Wise
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

2.  Bacteroides fragilis resistant to metronidazole, clindamycin and cefoxitin.

Authors:  O Brogan; P A Garnett; R Brown
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

3.  Efflux pumps and drug resistance in gram-negative bacteria.

Authors:  D Ma; D N Cook; J E Hearst; H Nikaido
Journal:  Trends Microbiol       Date:  1994-12       Impact factor: 17.079

4.  In vitro activity of BAY 12-8039, a new fluoroquinolone.

Authors:  J M Woodcock; J M Andrews; F J Boswell; N P Brenwald; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.

Authors:  K E Aldridge; D Ashcraft; K A Bowman
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

6.  Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli.

Authors:  H I Zgurskaya; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.

Authors:  L J Piddock; R N Walters; J M Diver
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

8.  Active efflux of norfloxacin by Bacteroides fragilis.

Authors:  S Miyamae; H Nikaido; Y Tanaka; F Yoshimura
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Properties of the penicillin-binding proteins of four species of the genus Bacteroides.

Authors:  L J Piddock; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

10.  Interaction of divalent cations, quinolones and bacteria.

Authors:  A J Marshall; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1994-10       Impact factor: 5.790

View more
  8 in total

1.  A resistance-nodulation-cell division family xenobiotic efflux pump in an obligate anaerobe, Porphyromonas gingivalis.

Authors:  Takeshi Ikeda; Fuminobu Yoshimura
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants.

Authors:  Vito Ricci; Marnie L Peterson; John C Rotschafer; Hannah Wexler; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

3.  Spectrofluorimetric quantification of antibiotic drug concentration in bacterial cells for the characterization of translocation across bacterial membranes.

Authors:  Julia Vergalli; Estelle Dumont; Jelena Pajović; Bertrand Cinquin; Laure Maigre; Muriel Masi; Matthieu Réfrégiers; Jean-Marie Pagés
Journal:  Nat Protoc       Date:  2018-05-17       Impact factor: 13.491

Review 4.  The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.

Authors:  Michelle F Richter; Paul J Hergenrother
Journal:  Ann N Y Acad Sci       Date:  2018-02-15       Impact factor: 5.691

5.  Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola.

Authors:  Catherine A Brissette; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

6.  Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Authors:  S Raherison; P Gonzalez; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.

Authors:  Oliver Langer; Martin Brunner; Markus Zeitlinger; Sophie Ziegler; Ulrich Müller; Georg Dobrozemsky; Edith Lackner; Christian Joukhadar; Markus Mitterhauser; Wolfgang Wadsak; Erich Minar; Robert Dudczak; Kurt Kletter; Markus Müller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

8.  Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution.

Authors:  Slávka Kaščáková; Laure Maigre; Jacqueline Chevalier; Matthieu Réfrégiers; Jean-Marie Pagès
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.